Cited by 1,106HIV Research and TreatmentHIV-related health complications and treatmentsHIV/AIDS Research and Interventions

The DOI matches its Crossref record; 53 of the 53 references it cites were found in a registry or an index.

. Plasma levels of soluble CD14 independently predict mortality in HIV infection.

Open access

Sandler, Netanya G., Wand, Handan, Roque, Annelys, Law, Matthew, Nason, Martha C., Nixon, Daniel E., Pedersen, Court, Ruxrungtham, Kiat, Lewin, Sharon R., Emery, Sean, Neaton, James D., Brenchley, Jason M., Deeks, Steven G., Sereti, Irini, Douek, Daniel C.·2011·The Journal of Infectious Diseases

DOI 10.1093/infdis/jiq118PMC PMC3071127

Open this paper in CoChat — free account Open PDF

Abstract

BACKGROUND: Chronic human immunodeficiency virus (HIV) infection is associated with intestinal permeability and microbial translocation that contributes to systemic immune activation, which is an independent predictor of HIV disease progression. The association of microbial translocation with clinical outcome remains unknown. METHODS: This nested case-control study included 74 subjects who died, 120 of whom developed cardiovascular disease and 81 of whom developed AIDS during the Strategies for Management of Anti-Retroviral Therapy (SMART) study with matched control subjects. Intestinal fatty acid binding protein (I-FABP), lipopolysaccharide (LPS), soluble CD14 (sCD14), endotoxin core antibody (EndoCAb), and 16S ribosomal DNA (rDNA) were measured in baseline plasma samples. RESULTS: Subjects with the highest quartile of sCD14 levels had a 6-fold higher risk of death than did those in the lowest quartile (95% confidence interval, 2.2-16.1; P<.001), with minimal change after adjustment for inflammatory markers, CD4(+) T cell count, and HIV RNA level. No other marker was significantly associated with clinical outcomes. I-FABP, LPS, and sCD14 were increased and EndoCAb was decreased in study subjects, compared with healthy volunteers. sCD14 level correlated with levels of IL-6, C-reactive protein, serum amyloid A and D-dimer. CONCLUSIONS: sCD14, a marker of monocyte response to LPS, is an independent predictor of mortality in HIV infection. Therapeutic attenuation of innate immune activation may improve survival in patients with HIV infection.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1093/infdis/jiq118

Cites

53 of 53 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Microbial translocation is a cause of systemic immune activation in chronic HIV infection
Brenchley, J. M., Price, D. A., Schacker, T. W., Asher, T. E., Silvestri, G., Rao, S., Kazzaz, Z., Bornstein, E., Lambotte, O., Altmann, D., et al. (2006) · Nature Medicine · doi:10.1038/nm1511 · Cited by 3,559
Self-citation
CD4+ Count–Guided Interruption of Antiretroviral Treatment
The Strategies for Management of Antiretroviral Therapy (SMART) Study Group (2006) · New England Journal of Medicine · doi:10.1056/nejmoa062360 · Cited by 2,250
CD4+ T Cell Depletion during all Stages of HIV Disease Occurs Predominantly in the Gastrointestinal Tract
Brenchley, J. M., Schacker, T. W., Ruff, L. E., Price, D. A., Taylor, J. H., Beilman, G. J., Nguyen, P. L., Khoruts, A., Larson, M. C., Haase, A. T., et al. (2004) · The Journal of Experimental Medicine · doi:10.1084/jem.20040874 · Cited by 1,836
Self-citation
. Inflammatory and coagulation biomarkers and mortality in patients with HIV infection.
Kuller, L. H., Tracy, R., Belloso, W., Wit, S. D., Drummond, F., Lane, H. C., Ledergerber, B., Lundgren, J., Neuhaus, J., Nixon, D., et al. (2008) · PLoS Medicine · doi:10.1371/journal.pmed.0050203 · Cited by 1,617
Self-citation
Gastrointestinal Tract as a Major Site of CD4 + T Cell Depletion and Viral Replication in SIV Infection
Veazey, R. S., DeMaria, M. A., Chalifoux, L. V., Shvetz, D. E., Pauley, D. R., Knight, H., Rosenzweig, M., Johnson, R. P., Desrosiers, R. C., & Lackner, A. A. (1998) · Science · doi:10.1126/science.280.5362.427 · Cited by 1,404
LPS, TLR4 and infectious disease diversity
Miller, S., Ernst, R. K., & Bader, M. W. (2005) · Nature Reviews Microbiology · doi:10.1038/nrmicro1068 · Cited by 1,059
Shorter Survival in Advanced Human Immunodeficiency Virus Type 1 Infection Is More Closely Associated with T Lymphocyte Activation than with Plasma Virus Burden or Virus Chemokine Coreceptor Usage
Giorgi, J. V., Hultin, L. E., McKeating, J. A., Johnson, T. D., Owens, B. M., Jacobson, L. P., Shih, R., Lewis, J., Wiley, D. J., Phair, J. P., et al. (1999) · The Journal of Infectious Diseases · doi:10.1086/314660 · Cited by 1,032
T Cell Activation Is Associated with Lower CD4+T Cell Gains in Human Immunodeficiency Virus–Infected Patients with Sustained Viral Suppression during Antiretroviral Therapy
Hunt, P. W., Martin, J. N., Sinclair, E., Bredt, B. M., Hagos, E., Lampiris, H. W., & Deeks, S. G. (2003) · The Journal of Infectious Diseases · doi:10.1086/374786 · Cited by 852
Self-citation
Immune activation set point during early HIV infection predicts subsequent CD4+ T-cell changes independent of viral load
Deeks, S. G., Ramirez, C. M., Liu, L., Guo, H., Gascon, R., Narváez, A. B., Hunt, P. W., Martin, J. N., Kahn, J. S., Levy, J. A., et al. (2004) · Blood · doi:10.1182/blood-2003-09-3333 · Cited by 803
Self-citation
Plasma Levels of Bacterial DNA Correlate with Immune Activation and the Magnitude of Immune Restoration in Persons with Antiretroviral‐Treated HIV Infection
Jiang, W., Lederman, M. M., Hunt, P. W., Sieg, S. F., Haley, K. P., Rodriguez, B. A., LANDAY, A. L., Martin, J. N., Sinclair, E., Asher, A. I., et al. (2009) · The Journal of Infectious Diseases · doi:10.1086/597476 · Cited by 598
Self-citation

Show all 50 references

Sorted by citations

Items 701–800 of 1,000

An investigation of the role of soluble CD14 in hospitalized, sick horses
Silva, A., Wagner, B., McKenzie, H. C., Desrochers, A. M., & Furr, M. O. (2013) · Veterinary Immunology and Immunopathology · doi:10.1016/j.vetimm.2013.08.007 · Cited by 12
sCD14 is not a bona-fide biomarker of microbial translocation in HIV-1-infected Africans living in Belgium
Voeght, A. D., Maes, N., & Moutschen, M. P. (2015) · AIDS · doi:10.1097/qad.0000000000000996 · Cited by 12
Neopterin and Soluble CD14 Levels as Indicators of Immune Activation in Cases with Indeterminate Pattern and True Positive HIV-1 Infection
Uysal, H. K., Sohrabi, P., Habip, Z., Sarıbaş, S., Kocazeybek, E., Seyhan, M. F., Çalışkan, R., Bonabi, E., Yüksel, P., Birinci, I., et al. (2016) · PLoS ONE · doi:10.1371/journal.pone.0152258 · Cited by 12
Aneurysmal vasculopathy in human-acquired immunodeficiency virus-infected adults: Imaging case series and review of the literature
Thawani, J. P., Nayak, N. R., Pisapia, J. M., Petrov, D., Pukenas, B. A., Hurst, R. W., & Smith, M. J. (2015) · Interventional Neuroradiology · doi:10.1177/1591019915581789 · Cited by 11
Immunologic biomarkers, morbidity and mortality among HIV patients hospitalised in a Tertiary Care Hospital in the Brazilian Amazon
Gama, W. M., Frank, C. H. M., Almeida, T. V. R., Santos, D. S., Chaves, Y. O., da Silva, D. F., Orlandi, P. P., Pereira, F. R., Magalhães, G. F., Baptista, B. J. A., et al. (2021) · BMC Infectious Diseases · doi:10.1186/s12879-021-06566-x · Cited by 11
Methadone use is associated with increased levels of sCD14, immune activation, and inflammation during suppressed HIV infection
Azzoni, L., Giron, L. B., Vadrevu, S. K., Zhao, L., Lalley-Chareczko, L., Hiserodt, E., Fair, M. G., Lynn, K., Trooskin, S. B., Mounzer, K., et al. (2022) · Journal of Leukocyte Biology · doi:10.1002/jlb.4a1221-678rr · Cited by 12
An open label randomized controlled trial of atorvastatin versus aspirin in elite controllers and antiretroviral-treated people with HIV
Mystakelis, H. A., Wilson, E. M. P., Laidlaw, E., Poole, A. L., Krishnan, S., Rupert, A. W., Welker, J. L., Gorelick, R. J., Lisco, A., Manion, M. M., et al. (2023) · AIDS · doi:10.1097/qad.0000000000003656 · Cited by 11
Self-citation
Virion-incorporated CD14 enables HIV-1 to bind LPS and initiate TLR4 signaling in immune cells
Persaud, A. T., Khela, J., Fernandes, C., Chaphekar, D., Burnie, J., Tang, V. A., Colpitts, C. C., & Guzzo, C. (2024) · Journal of Virology · doi:10.1128/jvi.00363-24 · Cited by 11
Mononuclear Phagocyte Accumulation in Visceral Tissue in HIV Encephalitis: Evidence for Increased Monocyte/Macrophage Trafficking and Altered Differentiation
Fischer, T., Wyatt, C. M., D’Agati, V. D., Croul, S. E., McCourt, L., Morgello, S., & Rappaport, J. (2014) · Current HIV Research · doi:10.2174/1570162x12666140713165141 · Cited by 11
Emphysema and soluble CD14 are associated with pulmonary nodules in HIV-infected patients
Triplette, M., Sigel, K. M., Morris, A. M., Shahrir, S., Wisnivesky, J. P., Kong, C. Y., Diaz, P. T., Petraglia, A., & Crothers, K. A. (2017) · AIDS · doi:10.1097/qad.0000000000001529 · Cited by 11
Modulation of Monocyte Activation and Function during Direct Antiviral Agent Treatment in Patients Coinfected with HIV and Hepatitis C Virus
Pablo-Bernal, R. S. D., Jiménez‐León, M. R., Tarancón‐Díez, L., Gutiérrez‐Valencia, A., Serna‐Gallego, A., Trujillo‐Rodríguez, M., Álvarez‐Ríos, A. I., Milanés‐Guisado, Y., Espinosa, N., Roca-Oporto, C., et al. (2020) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00773-20 · Cited by 11
Relationship Between Anemia and Systemic Inflammation in People Living With HIV and Tuberculosis: A Sub-Analysis of the CADIRIS Clinical Trial
Araújo‐Pereira, M., Barreto‐Duarte, B., Arriaga, M. B., Musselwhite, L. W., Vinhaes, C. L., Belaunzarán-Zamudio, P. F., Rupert, A. W., Montaner, L. J., Lederman, M. M., Sereti, I., et al. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.916216 · Cited by 11
Self-citation
Pro-inflammatory and pro-resolving lipid mediators of inflammation in HIV: effect of aspirin intervention
Dalli, J., Kitch, D. W., O’Brien, M. P., Hunt, P. W., Funderburg, N., Moisi, D. D., Gupta, A., Brown, T. T., Tien, P. C., Aberg, J. A., et al. (2023) · EBioMedicine · doi:10.1016/j.ebiom.2023.104468 · Cited by 11
Increased Peripheral Inflammation Is Associated With Structural Brain Changes and Reduced Blood Flow in People With Virologically Controlled HIV
Burdo, T. H., Robinson, J. A., Cooley, S., Smith, M. D., Flynn, J., Petersen, K. J., Nelson, B., Westerhaus, E. T., Wisch, J. K., & Ances, B. M. (2023) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiad229 · Cited by 11
A Randomized Controlled Trial of Lisinopril to Decrease Lymphoid Fibrosis in Antiretroviral-Treated, HIV-infected Individuals
Cockerham, L. R., Yukl, S. A., Harvill, K., Somsouk, M., Joshi, S. K., Sinclair, E., Liegler, T. J., Hoh, R., Lyons, S., Hunt, P. W., et al. (2017) · Pathogens and Immunity · doi:10.20411/pai.v2i3.207 · Cited by 11
Self-citation
Brief Report: Pulmonary Tuberculosis Is Associated With Persistent Systemic Inflammation and Decreased HIV-1 Reservoir Markers in Coinfected Ugandans
Olson, A. J., Ragan, E. J., Nakiyingi, L., Lin, N., Jacobson, K. R., Ellner, J. J., Manabe, Y. C., & Sagar, M. (2018) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0000000000001823 · Cited by 11
A randomized pilot trial to evaluate the benefit of the concomitant use of atorvastatin and Raltegravir on immunological markers in protease-inhibitor-treated subjects living with HIV
Negredo, E., Jiménez, M., Puig, J., Loste, C., Pérez‐Álvarez, N., Urrea, V., Echeverría, P., Bonjoch, A., Clotet, B., & Blanco, J. (2020) · PLoS ONE · doi:10.1371/journal.pone.0238575 · Cited by 12
Association of Plasma Soluble Vascular Cell Adhesion Molecule-1 and sCD14 With Mortality in HIV-1–Infected West African Adults With High CD4 Counts
Affi, R., Gabillard, D., Dunyach‐Remy, C., Ntakpe, J.-B., Moh, R., Badjé, A., Kouamé, G. M., Karcher, S., Carrou, J. L., Danel, C., et al. (2020) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0000000000002533 · Cited by 11
Residual immune activation in HIV-Infected individuals expands monocytic-myeloid derived suppressor cells
Singh, R., Chakraborty, M., Gautam, A., Roy, S. K., Halder, I., Barber, J., & Garg, A. (2021) · Cellular Immunology · doi:10.1016/j.cellimm.2021.104304 · Cited by 10
Redistribution of brain glucose metabolism in people with HIV after antiretroviral therapy initiation
Wang, Z., Manion, M. M., Laidlaw, E., Rupert, A. W., Lau, C., Smith, B., Nath, A., Sereti, I., & Hammoud, D. A. (2021) · AIDS · doi:10.1097/qad.0000000000002875 · Cited by 11
Self-citation
Targeted plasma proteomics reveals upregulation of distinct inflammatory pathways in people living with HIV
Vadaq, N., de Wijer, L. V., van Eekeren, L. E., Koenen, H. J. P. M., de Mast, Q., Joosten, L. A. B., Netea, M. G., Matzaraki, V., & van der Ven, A. J. A. M. (2022) · iScience · doi:10.1016/j.isci.2022.105089 · Cited by 11
Biomarkers and Their Role in Detection of Biomolecules
Taj, A., Rehman, A., & Bajwa, S. Z. (2020) · doi:10.1002/9783527345137.ch4 · Cited by 11
Primary HIV infection features colonic damage and neutrophil inflammation yet containment of microbial translocation
Tincati, C., Bono, V., Cannizzo, E. S., Tosi, D., Savi, F., Falcinella, C., Casabianca, A., Orlandi, C., Luigiano, C., Augello, M., et al. (2023) · AIDS · doi:10.1097/qad.0000000000003799 · Cited by 10
The impact of glycosylation on the structure, function, and interactions of CD14
Quintana, J. I., Delgado, S., Rábano, M., Azkargorta, M., Florencio-Zabaleta, M., Unione, L., Vivanco, M. D., Elortza, F., Jiménez‐Barbero, J., & Ardá, A. (2024) · Glycobiology · doi:10.1093/glycob/cwae002 · Cited by 10
The Gut and the Translocated Microbiomes in HIV Infection: Current Concepts and Future Avenues
Nganou‐Makamdop, K., & Douek, D. C. (2024) · Pathogens and Immunity · doi:10.20411/pai.v9i1.693 · Cited by 10
Self-citation
Elucidating the Significance of Zonulin in the Pathogenesis of Chronic Inflammatory Disorders: Emphasis on Intestinal Barrier Function and Tight Junction Regulation
Mohammadi-Kordkhayli, M., Mousavi, M. J., Camara-Lemarroy, C. R., Noorbakhsh, F., & Saboor-Yaraghi, A. A. (2024) · Current Medicinal Chemistry · doi:10.2174/0109298673335863240829060545 · Cited by 12
Safety and efficacy of fecal microbiota transplantation for viral diseases: A systematic review of clinical trials
Ebrahimi, R., Masouri, M. M., Khozani, A. A. S. A., Hussein, D. R., & Nejadghaderi, S. A. (2024) · PLoS ONE · doi:10.1371/journal.pone.0311731 · Cited by 15
HIV, the gut microbiome and clinical outcomes, a systematic review
MacCann, R., Newman, E., Devane, D., Sabin, C. A., Cotter, A. G., LANDAY, A. L., O’Toole, P. W., & Mallon, P. W. G. (2024) · PLoS ONE · doi:10.1371/journal.pone.0308859 · Cited by 11
Dyslipidemia and statin use in people with HIV-1 infection: beyond the lipid-lowering effect
Gazzaniga, G., Ridolfi, M., Lazzaro, A., Brogi, T., Pignatelli, P., Pastori, D., & Mezzaroma, I. (2025) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2025.104110 · Cited by 10
Understanding residual risk of cardiovascular disease in people with HIV
Obare, L. M., Stephens, V. R., & Wanjalla, C. N. (2025) · Current Opinion in HIV and AIDS · doi:10.1097/coh.0000000000000953 · Cited by 10
Immune activation throughout a boosted darunavir monotherapy simplification strategy
BenMarzouk‐Hidalgo, O. J., Torres-Cornejo, A., Gutiérrez‐Valencia, A., Ruiz-Valderas, R., Viciana, P., López-Cortés, L. F., & Antonelli, G. (2013) · Clinical Microbiology and Infection · doi:10.1111/1469-0691.12521 · Cited by 10
Immunization of cows with novel core glycolipid vaccine induces anti-endotoxin antibodies in bovine colostrum
Cross, A. S., Karreman, H. J., Zhang, L., Rosenberg, Z., Opal, S. M., & Lees, A. (2014) · Vaccine · doi:10.1016/j.vaccine.2014.08.083 · Cited by 10
Immune Activation and Inflammation in People With Human Immunodeficiency Virus: Challenging Targets
Utay, N. S., & Overton, E. T. (2019) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiz351 · Cited by 10
Inflammation and microbial translocation measured prior to combination antiretroviral therapy (cART) and long-term probability of clinical progression in people living with HIV
Merlini, E., Cozzi‐Lepri, A., Castagna, A., Costantini, A., Caputo, S. L., Carrara, S., Quirós-Roldán, E., Ursitti, M. A., Antinori, A., Monforte, A. D., et al. (2021) · BMC Infectious Diseases · doi:10.1186/s12879-021-06260-y · Cited by 10
Plasma d-amino acids are associated with markers of immune activation and organ dysfunction in people with HIV
Yap, S. H., Lee, C. S., Furusho, A., Ishii, C., Shaharudin, S., Zulhaimi, N. S., Kamarulzaman, A., Kamaruzzaman, S. B., Mita, M., Leong, K. H., et al. (2022) · AIDS · doi:10.1097/qad.0000000000003207 · Cited by 11
The Interaction of HIV With Mental Health in the Modern Antiretroviral Therapy Era
Carrico, A. W., Rubin, L. H., & Paul, R. H. (2022) · Psychosomatic Medicine · doi:10.1097/psy.0000000000001134 · Cited by 10
Interplay between systemic inflammation, anemia, and mycobacterial dissemination and its impact on mortality in TB-associated HIV: a prospective cohort study
Araújo‐Pereira, M., Schutz, C., Barreto‐Duarte, B., Barr, D. A., Villalva-Serra, K., Vinhaes, C. L., Ward, A. M., Meintjes, G., & Andrade, B. B. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1177432 · Cited by 12
Cytokine dysregulation despite immunoglobulin replacement therapy in common variable immunodeficiency (CVID)
Poto, R., Pecoraro, A., Ferrara, A. L., Punziano, A., Lagnese, G., Messuri, C., Loffredo, S., Spadaro, G., & Varricchi, G. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1257398 · Cited by 11
Decreased monocyte activation with daily acyclovir use in HIV-1/HSV-2 coinfected women
Redd, A. D., Newell, K., Patel, E. U., Nalugoda, F. K., Ssebbowa, P., Kalibbala, S., Frank, M., Tobian, A. A. R., Gray, R. H., Quinn, T. C., et al. (2015) · Sexually Transmitted Infections · doi:10.1136/sextrans-2014-051867 · Cited by 10
Antiretroviral therapy in HIV-1-infected individuals with CD4 count below 100 cells/mm3 results in differential recovery of monocyte activation
Patro, S. C., Azzoni, L., Joseph, J., Fair, M. G., Sierra-Madero, J. G., Rassool, M. S., Sanne, I., & Montaner, L. J. (2015) · Journal of Leukocyte Biology · doi:10.1189/jlb.5ab0915-406r · Cited by 11
Brief Report: Circulating Markers of Immunologic Activity Reflect Adiposity in Persons With HIV on Antiretroviral Therapy
Koethe, J. R., Jenkins, C. A., Furch, B. D., Lake, J. E., Barnett, L. D., Hager, C. C., Smith, R. M., Hulgan, T., Shepherd, B. E., & Kalams, S. A. (2018) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0000000000001768 · Cited by 10
Bacteria-related Events and the Immunological Response of Onset and Relapse Adult Crohn’s Disease Patients
Cantó, E., Zamora, C., García-Planella, E., Gordillo, J., Ortiz, M. A., Perea, L., & Vidal, S. (2018) · Journal of Crohn s and Colitis · doi:10.1093/ecco-jcc/jjy138 · Cited by 10
Anaemia is Associated with Monocyte Activation in HIV-Infected Adults on Antiretroviral Therapy
Lipshultz, H., Hileman, C. O., Ahuja, S. P., Funderburg, N., & McComsey, G. A. (2014) · Antiviral Therapy · doi:10.3851/imp2940 · Cited by 10
Can an immune-regulatory vaccine prevent HIV infection?
Boettler, T., Cunha‐Neto, E., Kalil, J. E., & von Herrath, M. (2012) · Expert Review of Anti-infective Therapy · doi:10.1586/eri.11.178 · Cited by 10
Dyslipidemia, Atherosclerosis and Cardiovascular Disease: An Increasingly Important Triad in an Aging Population Living with HIV
O’Halloran, J. A., Satchell, C. S., & Mallon, P. W. G. (2013) · Future Virology · doi:10.2217/fvl.13.87 · Cited by 10
Elevated Levels of Microbial Translocation Markers and CCL2 Among Older HIV-1–Infected Men
Scully, E. P., Lockhart, A. A. K., Huang, L. P., Robles, Y., Becerril, C., Romero‐Tejeda, M., Albrecht, M., Palmer, C. D., Bosch, R. J., Altfeld, M. A., et al. (2015) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiv501 · Cited by 10
Long-term Use of Proton Pump Inhibitors Is Associated With Increased Microbial Product Translocation, Innate Immune Activation, and Reduced Immunologic Recovery in Patients With Chronic Human Immunodeficiency Virus-1 Infection
Serpa, J. A., Rueda, A. M., Somasunderam, A., Utay, N. S., Lewis, D. E., Couturier, J. P., Breaux, K., & Rodriguez‐Barradas, M. C. (2017) · Clinical Infectious Diseases · doi:10.1093/cid/cix609 · Cited by 10
Biomarkers of Inflammation Correlate With Clinical Scoring Indices in Human Immunodeficiency Virus–Infected Kenyans
Letizia, A. G., Eller, M. A., Polyak, C. S., Eller, L. A., Creegan, M., Dawson, P. M., Bryant, C., Kim, D., Crowell, T. A., Lombardi, K., et al. (2018) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiy509 · Cited by 10
Low-Level Ionizing Radiation Induces Selective Killing of HIV-1-Infected Cells with Reversal of Cytokine Induction Using mTOR Inhibitors
Pinto, D. O., DeMarino, C., Vo, T. T., Cowen, M., Kim, Y., Pleet, M. L., Barclay, R. A., Hooten, N. N., Evans, M. K., Heredia, A., et al. (2020) · Viruses · doi:10.3390/v12080885 · Cited by 10
Microbial Translocation and Infectious Diseases: What Is the Link?
d’Ettorre, G., Douek, D. C., Paiardini, M., Ceccarelli, G., & Vullo, V. (2012) · International Journal of Microbiology · doi:10.1155/2012/356981 · Cited by 10
Self-citation
Menopause and Estrogen Associations With Gut Barrier, Microbial Translocation, and Immune Activation Biomarkers in Women With and Without HIV
Peters, B. A., Hanna, D. B., Xue, X., Weber, K. M., Appleton, A. A., Kassaye, S. G., Topper, E. T., Tracy, R. P., Guillemette, C., Caron, P., et al. (2024) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0000000000003419 · Cited by 9
Inflammatory Biomarker Reduction With Fostemsavir Over 96 Weeks in Heavily Treatment-Experienced Adults With Multidrug-Resistant HIV-1 in the BRIGHTE Study
Clark, A., Prakash, M., Chabria, S., Pierce, A., Castillo‐Mancilla, J., Wang, M., Du, F., & Tenorio, A. R. (2024) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofae469 · Cited by 9
Associations of inflammatory markers with post-acute clinical findings among survivors of Ebola virus disease with and without viral RNA shedding in the semen in Liberia: a nested case–control study
Fallah, M. P., Ryn, C. V., Moses, J. S., Badio, M., Fayiah, T., Johnson, K., Gayedyu-Dennis, D., Eghrari, A. O., Weiser, S. D., Porco, T. C., et al. (2025) · The Lancet Microbe · doi:10.1016/j.lanmic.2024.101033 · Cited by 9
The Effects of Semaglutide on Inflammation and Immune Activation in HIV-associated Lipohypertrophy
Funderburg, N., Eckard, A. R., Wu, Q., Sattar, A., Ailstock, K., Cummings, M. J., Labbato, D. E., & McComsey, G. A. (2025) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofaf152 · Cited by 9
Comparable Inflammatory and Metabolic Outcomes After Switching to Bictegravir/Emtricitabine/Tenofovir Alafenamide Versus Continuing Dolutegravir/Lamivudine in Virologically Suppressed Adults With HIV (INSTINCT/GESIDA10918 Study)
Villar, S. S., Martín‐Pedraza, L., Tiraboschi, J. M., Novella, M., Cabello, A., López-Cortés, L. F., Busca, C., Torralba, M., Crusells, M. J., Hidalgo-Tenorio, C., et al. (2025) · Clinical Infectious Diseases · doi:10.1093/cid/ciaf565 · Cited by 10
From Steatosis to Immunosenescence: The Impact of Metabolic Dysfunction on Immune Aging in HIV and Non-HIV Populations
Acierno, C., Frontuto, M., Stefano, G. F. D., Erezanu, A., Limone, A., Morella, S., Picaro, F., Palazzo, D., & Gilio, M. (2025) · Biomedicines · doi:10.3390/biomedicines13102513 · Cited by 10
Residual Immune Activation and Latency
Bruzzesi, E., & Sereti, I. (2018) · Current topics in microbiology and immunology · doi:10.1007/82_2018_118 · Cited by 9
Self-citation
The Youngbloods. Get Together. Hypercoagulation, Complement, and NET Formation in HIV/SIV Pathogenesis
Reno, T. A., Tarnus, L., Tracy, R. P., LANDAY, A. L., Sereti, I., Apetrei, C., & Pandrea, I. (2022) · Frontiers in Virology · doi:10.3389/fviro.2021.795373 · Cited by 9
Self-citation
Cardiovascular Profile of South African Adults with Low-Level Viremia during Antiretroviral Therapy
Roux, S. B., Elvstam, O., Boever, P. D., Goswami, N., Magnusson, M., Nilsson, P. M., Strijdom, H., Björkman, P., & Fourie, C. M. T. (2022) · Journal of Clinical Medicine · doi:10.3390/jcm11102812 · Cited by 9
The IDOze Study: The Link Between Sleep Disruption and Tryptophan-Kynurenine Pathway Activation in Women With Human Immunodeficiency Virus
Rogando, A. C., Weber, K. M., Xing, J., Xue, X., Yohannes, T., Morack, R., Qi, Q., Clish, C. B., Bullock, K. H., Gustafson, D., et al. (2022) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiac287 · Cited by 9
Higher Soluble CD163 in Blood Is Associated With Significant Depression Symptoms in Men With HIV
Anderson, A. M. L., Bhondoekhan, F., Curanović, D., Connelly, M. A., Otvos, J. D., Post, W. S., Michos, E. D., Stosor, V., Levine, A. J., Seaberg, E. C., et al. (2022) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0000000000003063 · Cited by 9
T cell activation is insufficient to drive SIV disease progression
Apetrei, C., Gaufin, T., Brocca‐Cofano, E., Sivanandham, R., Sette, P., He, T., Sivanandham, S., Sosa, N. M., Martin, K. J., Raehtz, K. D., et al. (2023) · JCI Insight · doi:10.1172/jci.insight.161111 · Cited by 9
Deep Transcriptional Sequencing of Mucosal Challenge Compartment from Rhesus Macaques Acutely Infected with Simian Immunodeficiency Virus Implicates Loss of Cell Adhesion Preceding Immune Activation
Barrenäs, F., Palermo, R. E., Agricola, B. A., Agy, M. B., Aicher, L. D., Carter, V., Flanary, L., Green, R. R., McLain, R., Li, Q., et al. (2014) · Journal of Virology · doi:10.1128/jvi.00543-14 · Cited by 9
Myeloid Cells Enriched for a Dendritic Cell Population From People Living With HIV Have Altered Gene Expression Not Restored by Antiretroviral Therapy
Murray, S. M., Zhang, Y., Douek, D. C., & Sékaly, R. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.00261 · Cited by 9
Self-citation
Effects of Internet Cognitive-Behavioral Therapy on Depressive Symptoms and Surrogates of Cardiovascular Risk in Human Immunodeficiency Virus: A Pilot, Randomized, Controlled Trial
Gupta, S. K., Slaven, J. E., Liu, Z., Polanka, B. M., Freiberg, M. S., & Stewart, J. C. (2020) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofaa280 · Cited by 9
Modifications of CD4 T cells, CD4/CD8 ratio and serum levels of soluble CD14 in HIV-HCV-coinfected patients after sustained HCV response induced by direct-acting antiviral agents: influence of liver cirrhosis
Girón-Ortega, J. A., Márquez-Coello, M., Saborido, D. G., Arizcorreta, A., Cuesta‐Sancho, S., & González, J. A. G. (2021) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-021-04237-y · Cited by 10
Cocaine use associated gut permeability and microbial translocation in people living with HIV in the Miami Adult Study on HIV (MASH) cohort
Hernández, J., Tamargo, J. A., Martínez, S. S., Martin, H. R., Campa, A. L., Sékaly, R., Bordi, R., Sherman, K. E., Rouster, S. D., Meeds, H. L., et al. (2022) · PLoS ONE · doi:10.1371/journal.pone.0275675 · Cited by 9
Incident hypertension in older women and men with or at risk for HIV infection
Factor, S., Lo, Y., Schoenbaum, E. E., & Klein, R. (2013) · HIV Medicine · doi:10.1111/hiv.12010 · Cited by 9
Clinical and Immunologic Predictors of Death After an Acute Opportunistic Infection: Results from ACTG A5164
Grant, P., Komarow, L., Sanchez, A., Sattler, F. R., Asmuth, D. M., Pollard, R. B., & Zolopa, A. R. (2014) · HIV Clinical Trials · doi:10.1310/hct1504-133 · Cited by 9
Study design issues in evaluating immune biomarkers
Bosch, R. J., Zhang, X., & Utay, N. S. (2013) · Current Opinion in HIV and AIDS · doi:10.1097/coh.0b013e32835d3259 · Cited by 8
Intestinal Barrier Impairment and Immune Activation in HIV-Infected Advanced Late Presenters are Not Dependent on CD4 Recovery
Wójcik, K., Piekarska, A., & Jabłonowska, E. (2018) · Archivum Immunologiae et Therapiae Experimentalis · doi:10.1007/s00005-018-0508-8 · Cited by 9
Heme-Induced Macrophage Phenotype Switching and Impaired Endogenous Opioid Homeostasis Correlate with Chronic Widespread Pain in HIV
Chatterjee, T., Arora, I., Underwood, L., Lewis, T. L., Juncos, J. X. M., Heath, S. L., Goodin, B. R., & Aggarwal, S. (2023) · Cells · doi:10.3390/cells12121565 · Cited by 8
Relationship between Modern ART Regimens and Immunosenescence Markers in Patients with Chronic HIV Infection
Grozdeva, R., Ivanov, D. T., Strashimirov, D., Kapincheva, N., Yordanova, R., Mihailova, S. M., Georgieva, A., Alexiev, I., Grigorova, L., Partsuneva, A., et al. (2024) · Viruses · doi:10.3390/v16081205 · Cited by 10
SARS-CoV-2 infection perturbs the gastrointestinal tract and induces modest microbial translocation across the intestinal barrier
Brooks, K., Nelson, C. E., Aguilar, C. C., Hoang, T. N., Ortiz, A. M., Langner, C. A., Yee, D. S., Flynn, J. K., Vrba, S. M., Laidlaw, E., et al. (2024) · Journal of Virology · doi:10.1128/jvi.01288-24 · Cited by 10
Self-citation
State of the Art of Dual Therapy in 2015
Nozza, S., Svicher, V., Saracino, A., d’Ettorre, G., Luca, A. D., Maggiolo, F., Bonora, S., Biagio, A. D., Rusconi, S., & Mussini, C. (2017) · Aids Reviews · doi:10.24875/aids.15000001 · Cited by 8
Biomarkers and Clinical Indices of Aging with HIV
Fitch, K. V., Feldpausch, M. N., & Looby, S. E. D. (2016) · Interdisciplinary topics in gerontology and geriatrics · doi:10.1159/000448543 · Cited by 8
The Pathogenesis of Liver Disease in People Living With Human Immunodeficiency Virus: The Emerging Role of the Microbiome
Kardashian, A. A., Peters, M. G., Tien, P. C., & Price, J. C. (2020) · Clinical Liver Disease · doi:10.1002/cld.880 · Cited by 8
Brief Report: Subclinical Carotid Artery Atherosclerosis Is Associated With Increased Expression of Peripheral Blood IL-32 Isoforms Among Women Living With HIV
Far, M. E., Hanna, D. B., Durand, M., Larouche-Anctil, E., Sylla, M., Chartrand‐Lefebvre, C., Cloutier, G., Goulet, J. P., Kassaye, S. G., Karim, R., et al. (2021) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0000000000002746 · Cited by 8
Transcription Factor ZNF683 Inhibits SIV/HIV Replication through Regulating IFNγ Secretion of CD8+ T Cells
Lu, Y., Zhang, M., Pang, W., Song, T., Zheng, H., Tian, R., & Zheng, Y. (2022) · Viruses · doi:10.3390/v14040719 · Cited by 8
Chronic Morphine Treatment and Antiretroviral Therapy Exacerbate HIV-Distal Sensory Peripheral Neuropathy and Induce Distinct Microbial Alterations in the HIV Tg26 Mouse Model
Chupikova, I., Antoine, D., Jalodia, R., Singh, P. K., & Roy, S. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25031569 · Cited by 9
Vitamin D status in Well‐Controlled Caucasian HIV Patients in Relation to Inflammatory and Metabolic Markers – A Cross‐Sectional Cohort Study in Sweden
Missailidis, C., Höijer, J., Johansson, M., Ekström, L., Bratt, G., Hejdeman, B., & Bergman, P. (2015) · Scandinavian Journal of Immunology · doi:10.1111/sji.12299 · Cited by 8
The clinical implications of HIV infection and aging
John, M. D. V. (2016) · Oral Diseases · doi:10.1111/odi.12473 · Cited by 9
Serum suppression of tumorigenicity 2 level is an independent predictor of all-cause mortality in HIV-infected patients
Thiébaut, R., Hüe, S., Marec, F. L., Lelièvre, J., Dupon, M., Foucat, E., Lazaro, E., Dabis, F., Duffau, P., Wittkop, L., et al. (2017) · AIDS · doi:10.1097/qad.0000000000001628 · Cited by 8
Gene expression profiling informs HPV cervical histopathology but not recurrence/relapse after LEEP in ART-suppressed HIV+HPV+ women
Papasavvas, E., Kossenkov, A. V., Azzoni, L., Zetola, N. M., Mackiewicz, A., Ross, B. N., Fair, M. G., Vadrevu, S. K., Ramogola‐Masire, D., Sanne, I., et al. (2018) · Carcinogenesis · doi:10.1093/carcin/bgy149 · Cited by 8
Myeloid and lymphoid activation markers in AIDS and non-AIDS presenters
Iannetta, M., Savinelli, S., Rossi, R., Mascia, C., Marocco, R., Vita, S., Zuccalà, P., Zingaropoli, M. A., Mengoni, F., Massetti, A. P., et al. (2018) · Immunobiology · doi:10.1016/j.imbio.2018.11.011 · Cited by 8
Biomarkers of Cellular Stress Do Not Associate with sCD14 in Progressive HIV and SIV Infections in Vivo
Vinton, C. L., Starke, C. E., Ortiz, A. M., Lai, S. H., Flynn, J. K., Sortino, O., Knox, K. S., Sereti, I., & Brenchley, J. M. (2020) · Pathogens and Immunity · doi:10.20411/pai.v5i1.363 · Cited by 8
Self-citation
Markers of gut dysfunction do not explain low rifampicin bioavailability in HIV-associated TB
Vinnard, C., Ravimohan, S., Tamuhla, N., Pasipanodya, J. G., Srivastava, S., Modongo, C., Zetola, N. M., Weissman, D., Gumbo, T., & Bisson, G. P. (2017) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkx111 · Cited by 8
Assessing the differential impact of chronic CMV and treated HIV infection on CD8+ T-cell differentiation in a matched cohort study: is CMV the key?
Mueller, M. C., Kern, W. V., Usadel, S., Pauly, M.-C., Cathomen, T., & Salzer, U. (2021) · AIDS Research and Therapy · doi:10.1186/s12981-021-00361-z · Cited by 8
Exacerbation of CMV and Nontuberculous Mycobacterial Infections Following PD-1 Blockade for HIV-Associated Kaposi Sarcoma
Anidi, I. U., Sakai, S., Brooks, K., Fling, S. P., Wagner, M. J., Lurain, K. A., Arlehamn, C. S. L., Sette, A., Knox, K. S., Brenchley, J. M., et al. (2024) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofae183 · Cited by 7
Self-citation
The Anti-inflammatory Effects of Cotrimoxazole Prophylaxis for People Living With Human Immunodeficiency Virus in Sub-Saharan Africa
Bourke, C. D., & Prendergast, A. J. (2019) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiz495 · Cited by 7
Immune activation and inflammation in lactating women on combination antiretroviral therapy: role of gut dysfunction and gut microbiota imbalance
Munjoma, P. T., Chandiwana, P., Wyss, J., Mazhandu, A. J., Jordi, S. B. U., Gutsire, R., Katsidzira, L., Yılmaz, B., Misselwitz, B., & Duri, K. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1280262 · Cited by 7
Beginning Antiretroviral Therapy for Patients with HIV
Johnson, J. A., & Sax, P. E. (2014) · Infectious Disease Clinics of North America · doi:10.1016/j.idc.2014.06.003 · Cited by 7
Neither Microbial Translocation Nor TLR Responsiveness Are Likely Explanations for Preexisting Immune Activation in Women Who Subsequently Acquired HIV in CAPRISA 004
Naranbhai, V., Samsunder, N., Utay, N. S., Roque, A., Karim, Q. A., Ndung’u, T., Carr, W. H., Altfeld, M. A., Douek, D. C., & Karim, S. S. A. (2013) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0b013e31828e604b · Cited by 7
Self-citation
Cardiovascular Disease in Patients with HIV
Knudsen, A., Kristoffersen, U. S., Kjær, A., & Lebech, A. (2012) · Future Virology · doi:10.2217/fvl.12.25 · Cited by 7
Asymptomatic HIV People Present Different Profiles of sCD14, sRAGE, DNA Damage, and Vitamins, according to the Use of cART and CD4+T Cell Restoration
Tasca, K. I., Corrêa, C. R., Caleffi, J. T., Mendes, M. B., Gatto, M., Manfio, V. M., de Camargo, C. C., Tavares, F. C., Biasin, M., & de Souza, L. D. R. (2018) · Journal of Immunology Research · doi:10.1155/2018/7531718 · Cited by 7
Cardiovascular Disease Risk Among Transgender People with HIV
Cetlin, M. D., Fulda, E. S., Chu, S. M., Hamnvik, O. R., Poteat, T., Zanni, M. V., & Toribio, M. P. (2021) · Current HIV/AIDS Reports · doi:10.1007/s11904-021-00572-z · Cited by 7
Gut Dysfunction Markers Are Associated With Body Composition in Youth Living With Perinatally Acquired Human Immunodeficiency Virus
Dirajlal‐Fargo, S., Jacobson, D. L., Yu, W., Mirza, A., Geffner, M. E., Jao, J. K., & McComsey, G. A. (2022) · Clinical Infectious Diseases · doi:10.1093/cid/ciac053 · Cited by 7
Improved induced innate immune response after cART initiation in people with HIV
Hove‐Skovsgaard, M., Møller, D. L., Hald, A., Gerstoft, J., Lundgren, J. D., Ostrowski, S. R., & Nielsen, S. D. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.974767 · Cited by 7
Switch to maraviroc/raltegravir dual therapy leads to an unfavorable immune profile with low-level HIV viremia
Campillo-Gimenez, L., Assoumou, L., Valantin, M., Pajanirassa, P., Villemonteix, J., Soulié, C., Marcelin, A., Costagliola, D. G., Capeau, J., Autran, B., et al. (2015) · AIDS · doi:10.1097/qad.0000000000000626 · Cited by 7
Latent TGF ‐β1 is Compartmentalized Between Blood and Seminal Plasma of HIV ‐Positive Men and Its Activation in Semen is Negatively Correlated with Viral Load and Immune Activation
Kafka, J. K., Osborne, B., Sheth, P. M., Nazli, A., Dizzell, S. E., Huibner, S., Kovacs, C. C., Verschoor, C. P., Bowdish, D. M. E., Kaul, R., et al. (2014) · American Journal of Reproductive Immunology · doi:10.1111/aji.12300 · Cited by 7

Authors: Sandler, N. G., Wand, H., Roque, A., Law, M., Nason, M. C., Nixon, D. E., Pedersen, C., Ruxrungtham, K., Lewin, S. R., Emery, S., Neaton, J. D., Brenchley, J. M., Deeks, S. G., Sereti, I., & Douek, D. C.
Affiliations: UNSW Sydney (AU)
National Institutes of Health (US)
Virginia Commonwealth University (US)
University of Southern Denmark (DK)
Chulalongkorn University (TH)
Burnet Institute (AU)
University of Minnesota (US)
San Francisco General Hospital (US)
ORCID: Wand, Handan
Law, Matthew
Nason, Martha C.
Ruxrungtham, Kiat
Lewin, Sharon R.
Emery, Sean
Neaton, James D.
Brenchley, Jason M.
Deeks, Steven G.
Sereti, Irini
Douek, Daniel C.
Venue: The Journal of Infectious Diseases
Publisher: Oxford University Press (OUP)
Published: 2011-03-15
Volume: 203
Issue: 6
Pages: 780-790
ISSN: 0022-1899 (ISSN-L)
1537-6613
DOI: 10.1093/infdis/jiq118
PMC: PMC3071127
OpenAlex: W2098152094
Cited by: 1,106
References: 50
Citations by year: 2026: 32 · 2025: 31 · 2024: 59 · 2023: 48 · 2022: 67 · 2021: 70 · 2020: 76 · 2019: 70 · 2018: 69 · 2017: 83 · 2016: 107 · 2015: 97 · 2014: 111 · 2013: 93 · 2012: 65
FWCI: 37.22
Type: journal article
Language: en
Open access: bronze
doi.org
Locations: The Journal of Infectious Diseases (publishedVersion)
PubMed Central (publishedVersion)
PubMed (publishedVersion)
University of Southern Denmark Research Portal (University of Southern Denmark) (submittedVersion)
Funders: National Center for Genetic Engineering and Biotechnology
National Institutes of Health
National Institute of Allergy and Infectious Diseases (AI 76174, P01AI076174)
Topics: Life Sciences › Immunology and Microbiology › Virology › HIV Research and Treatment
Health Sciences › Medicine › Infectious Diseases › HIV-related health complications and treatments
Health Sciences › Medicine › Infectious Diseases › HIV/AIDS Research and Interventions
Keywords: soluble CD14, HIV infection, mortality prediction, microbial translocation, intestinal permeability, lipopolysaccharide, endotoxin core antibody, intestinal fatty acid binding protein, cardiovascular disease, AIDS, innate immune activation, SMART trial, prognostic factors
MeSH terms: Adult, Cause of Death, Humans, Lipopolysaccharides, Male, Middle Aged, RNA, Viral, Biomarkers, CD4-Positive T-Lymphocytes, HIV Infections, Logistic Models, Case-Control Studies, Lipopolysaccharide Receptors, Fatty Acid-Binding Proteins, Young Adult

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

. Plasma levels of soluble CD14 independently predict mortality in HIV infection.

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks